Targeting MicroRNA Function in Respiratory Diseases: Mini-Review

Area of Science:

• Molecular Biology
• Genetics
• Pulmonology

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
• miRNAs play roles in various biological processes and are explored as disease biomarkers and therapeutic targets.
• Currently, no miRNA-targeted therapies are approved for respiratory diseases, despite their potential.

Purpose of the Study:

• To review current knowledge on miRNA expression and function in respiratory diseases.
• To discuss intervention strategies for targeting miRNA function in lung conditions.
• To highlight considerations specific to respiratory disease miRNA therapeutics.

Main Methods:

• Literature review of studies on miRNA expression in respiratory diseases.
• Analysis of miRNA alterations in lung tissue and accessible body fluids.
• Examination of preclinical and clinical data on miRNA-targeted interventions.

Main Results:

• Altered miRNA profiles are observed in asthma, COPD, cystic fibrosis, and idiopathic pulmonary fibrosis.
• Changes in miRNA levels in sputum, serum, and other fluids suggest potential diagnostic biomarkers.
• Preclinical studies show promising results for direct lung administration of miRNA-targeting molecules.

Conclusions:

• miRNAs are implicated in the pathogenesis of major respiratory diseases.
• Accessible body fluids containing miRNAs may serve as valuable diagnostic and prognostic biomarkers.
• Direct lung delivery of miRNA therapeutics presents a promising strategy for respiratory diseases with potential for reduced side effects.